(Q43740197)

26 November 2017

Management of Stage D1 Adenocarcinoma of the Prostate: The Johns Hopkins Experience 1974 to 1987 (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

2 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

2 November 2022

author name string

G. D. Steinberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700157

2 November 2022

J. I. Epstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700157

2 November 2022

S. Piantadosi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700157

2 November 2022

P. C. Walsh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700157

2 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

full work available at URL

26 November 2017

https://api.elsevier.com/content/article/PII:S0022534717397598?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

https://api.elsevier.com/content/article/PII:S0022534717397598?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2939759-8

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

2 November 2022

1 reference

26 November 2017

144

1 reference

26 November 2017

1425-1432

1 reference

26 November 2017

6

1 reference

Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations.

26 November 2017

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostate

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Nonparametric Estimation from Incomplete Observations

2 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Prognosis of Patients With Stage D1 Prostatic Adenocarcinoma

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Nodal involvement as a prognostic indicator in patients with prostatic carcinoma

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Extended field radiation therapy for prostate cancer: Influence of positive lymph nodes on prognosis

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Adjuvant chemotherapy for stage D1 adenocarcinoma of prostate

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Intermediate-Term Survival Results in Clinically Understaged Prostate Cancer Patients Following Radical Prostatectomy

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Result of treatment of patients with stage D1 prostatic carcinoma

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Observations on surgical management of carcinoma of prostate with limited nodal metastases

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastasis from adenocarcinoma of the prostate

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.

2 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39759-8

2 November 2022

Identifiers

1 reference

26 November 2017

1 reference